Home › Funds › Eversept Partners, LP › ASND

Eversept Partners, LP position in ASND

ASCENDIS PHARMA A/S · Health Care

Eversept Partners, LP reported holding 41,621 shares of ASND (ASCENDIS PHARMA A/S) in its Q2 2026 13F filing — a position valued at US$11.1M, representing 0.58% of its reported portfolio and ranking #43 among its reported holdings. Eversept Partners, LP has disclosed ASND holdings in 2 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)41.62K sh
Reported value held$11.10M
Portfolio Weight0.58%
First reportedQ4 2025
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Eversept Partners, LP's ASND position evolved

Eversept Partners, LP first disclosed a stake in ASND in Q4 2025 at 48,241 shares (US$10.3M). The position peaked in Q2 2026 at 41,621 shares, worth US$11.1M. Across 2 filings, Eversept Partners, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 41,621 shares valued at US$11.1M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 48.24K $10.29M New
Q2 2026 41.62K $11.10M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ASND and 13F data

ASND (ASCENDIS PHARMA A/S) is a Health Care company. 43 other funds we track also report a position in ASND — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$2.74B), T. Rowe Price Investment Management, Inc. (US$1.80B), Avoro Capital Advisors LLC (US$1.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ASND

All ASND fund holders →

FAQ

How long has Eversept Partners, LP held ASND?

Eversept Partners, LP has disclosed ASND holdings in 2 of the last 3 reported quarters, going back to Q4 2025.

What is Eversept Partners, LP's current position in ASND?

As of Q2 2026, Eversept Partners, LP holds 41.62K shares of ASND (ASCENDIS PHARMA A/S), valued at $11.10M, representing 0.58% of its reported portfolio and ranking #43.

Has Eversept Partners, LP been buying or selling ASND?

In the latest 13F filing (Q2 2026), Eversept Partners, LP newly opened its position in ASND. The position peaked in Q2 2026 at 41.62K shares.

Which other funds hold ASND?

Other major institutional holders of ASND include RA CAPITAL MANAGEMENT, L.P., T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.